Document Detail

Complete abolition of the reentrant supraventricular tachycardia zone using a new modality of cardiac pacing with simultaneous atrioventricular stimulation.
MedLine Citation:
PMID:  7350776     Owner:  NLM     Status:  MEDLINE    
In an attempt to prevent recurrent reentrant supraventricular tachycardia, an experimentally designed new pacemaker has been developed. The pacemaker, when connected to both atrial and ventricular electrodes, is capable of sensing either an atrial or ventricular signal and, in turn, triggers simultaneous atrioventricular A-V) stimulation. Efficacy of this pacemake was tested in four patients with recurrent paroxysmal A-V nodal reentrant tachycardia during electrophysiologic studies. After connection of the electrodes to the new pacemaker, all atrial or ventricular premature stimuli elicited simultaneous A-V stimulation with resultant impulse collision in the A-V junction. Consequently, the reentrant tachycardia zone was completely abolished in all patients. This study has thus demonstrated the clinical feasibility of simultaneous A-V pacing to abolish the supraventricular tachycardia zone in man.
R J Sung; J L Styperek; A Castellanos
Related Documents :
15227476 - Indications and choices in pacemaker therapy.
17704096 - Late left ventricular lead displacement and treatment with a new endovenous active fixa...
25150586 - High serum levels of thrombospondin-2 correlate with poor prognosis of patients with he...
25161046 - The evolution from fibrinolytic therapy to a fibrinolytic strategy for patients with st...
2483236 - Beta-blockers in chronic treatment after acute myocardial infarction.
9807666 - Bradykinin mediates myocardial ischaemic preconditioning against free radical injury in...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  45     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1980 Jan 
Date Detail:
Created Date:  1980-02-28     Completed Date:  1980-02-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  72-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atrioventricular Node / physiopathology*
Cardiac Pacing, Artificial*
Digoxin / therapeutic use
Follow-Up Studies
Heart Conduction System / physiopathology*
Heart Ventricles / physiopathology
Middle Aged
Propranolol / therapeutic use
Quinidine / therapeutic use
Tachycardia / drug therapy,  physiopathology*
Time Factors
Verapamil / therapeutic use
Reg. No./Substance:
20830-75-5/Digoxin; 52-53-9/Verapamil; 525-66-6/Propranolol; 56-54-2/Quinidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evidence for a flow-independent contribution to the phenomenon of thallium redistribution.
Next Document:  Spectrum of cardiovascular lesions in mucocutaneous lymph node syndrome: analysis of eight cases.